You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 9, 2024

Details for Patent: 11,000,520

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 11,000,520 protect, and when does it expire?

Patent 11,000,520 protects SUBLOCADE and is included in one NDA.

This patent has ten patent family members in nine countries.

Summary for Patent: 11,000,520

Title:	Buprenorphine dosing regimens
Abstract:	The disclosure provides a dosage regimen using sustained-release buprenorphine formulations to produce therapeutic levels of buprenorphine in patients for the treatment of pain or opioid use disorders.
Inventor(s):	Nasser; Azmi (Richmond, VA), Laffont; Celine M (Richmond, VA), Heidbreder; Christian (Richmond, VA)
Assignee:	Indivior UK Limited (Hull, GB)
Application Number:	15/523,986
Patent Claim Types: see list of patent claims	Use; Composition;

Drugs Protected by US Patent 11,000,520

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Indivior	SUBLOCADE	buprenorphine	SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS	209819-001	Nov 30, 2017		RX	Yes	No	⤷ Try a Trial	⤷ Try a Trial				TREATING OPIOID USE DISORDER	⤷ Try a Trial
Indivior	SUBLOCADE	buprenorphine	SOLUTION, EXTENDED RELEASE;SUBCUTANEOUS	209819-002	Nov 30, 2017		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				TREATING OPIOID USE DISORDER	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 11,000,520

PCT Information
PCT Filed	November 06, 2015	PCT Application Number:	PCT/IB2015/002269
PCT Publication Date:	May 12, 2016	PCT Publication Number:	WO2016/071767

International Family Members for US Patent 11,000,520

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2015341490	⤷ Try a Trial
Canada	2965895	⤷ Try a Trial
Canada	3015557	⤷ Try a Trial
Denmark	3215223	⤷ Try a Trial
European Patent Office	3215223	⤷ Try a Trial
Spain	2808150	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.